サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/05/01 | 2,069 | 2,083 | 2,039.5 | 2,056 | +6.5 | +0.3% | 308,300 |
2025/04/30 | 2,059.5 | 2,067 | 2,043.5 | 2,049.5 | +8.5 | +0.4% | 357,200 |
2025/04/28 | 2,056 | 2,059 | 2,032.5 | 2,041 | -2.5 | -0.1% | 453,600 |
2025/04/25 | 2,044 | 2,053 | 2,030.5 | 2,043.5 | -0.5 | ±0% | 264,600 |
2025/04/24 | 2,049 | 2,068 | 2,023 | 2,044 | +6 | +0.3% | 289,100 |
2025/04/23 | 2,050 | 2,052 | 2,021.5 | 2,038 | +33.5 | +1.7% | 328,700 |
2025/04/22 | 1,979.5 | 2,022.5 | 1,952 | 2,004.5 | +33.5 | +1.7% | 500,800 |
2025/04/21 | 1,968 | 1,973 | 1,947.5 | 1,971 | +11 | +0.6% | 193,400 |
2025/04/18 | 1,953 | 1,978 | 1,934 | 1,960 | +46.5 | +2.4% | 209,100 |
2025/04/17 | 1,912 | 1,919 | 1,902.5 | 1,913.5 | -11 | -0.6% | 214,800 |
2025/04/16 | 1,911.5 | 1,924.5 | 1,892.5 | 1,924.5 | +19.5 | +1% | 306,700 |
2025/04/15 | 1,897 | 1,909 | 1,893.5 | 1,905 | +10 | +0.5% | 272,500 |
2025/04/14 | 1,892 | 1,913 | 1,882 | 1,895 | +32.5 | +1.7% | 447,700 |
2025/04/11 | 1,850 | 1,864.5 | 1,820 | 1,862.5 | -52.5 | -2.7% | 427,100 |
2025/04/10 | 1,834.5 | 1,917 | 1,828 | 1,915 | +90.5 | +5% | 764,900 |
2025/04/09 | 1,830.5 | 1,845 | 1,796 | 1,824.5 | -33.5 | -1.8% | 808,500 |
2025/04/08 | 1,850 | 1,867.5 | 1,821.5 | 1,858 | +49 | +2.7% | 697,000 |
2025/04/07 | 1,817.5 | 1,862 | 1,794.5 | 1,809 | -128.5 | -6.6% | 831,500 |
2025/04/04 | 1,919.5 | 1,958 | 1,906 | 1,937.5 | -2.5 | -0.1% | 552,400 |
2025/04/03 | 1,900 | 1,955.5 | 1,893 | 1,940 | +0.5 | ±0% | 746,400 |
2025/04/02 | 1,980 | 1,980 | 1,936.5 | 1,939.5 | -60.5 | -3% | 402,200 |
2025/04/01 | 2,000 | 2,011.5 | 1,988 | 2,000 | +18.5 | +0.9% | 511,100 |
2025/03/31 | 2,011 | 2,015 | 1,957 | 1,981.5 | -65 | -3.2% | 671,400 |
2025/03/28 | 2,055 | 2,072.5 | 2,033 | 2,046.5 | -53.5 | -2.5% | 513,400 |
2025/03/27 | 2,096.5 | 2,102.5 | 2,074 | 2,100 | +3.5 | +0.2% | 480,200 |
2025/03/26 | 2,085 | 2,106 | 2,080.5 | 2,096.5 | -3.5 | -0.2% | 430,600 |
2025/03/25 | 2,105 | 2,129 | 2,085 | 2,100 | -28.5 | -1.3% | 416,000 |
2025/03/24 | 2,105 | 2,158 | 2,100.5 | 2,128.5 | +26.5 | +1.3% | 917,200 |
2025/03/21 | 2,094 | 2,118.5 | 2,091.5 | 2,102 | +3.5 | +0.2% | 667,300 |
2025/03/19 | 2,103 | 2,125.5 | 2,096 | 2,098.5 | -1.5 | -0.1% | 321,000 |
2025/03/18 | 2,070 | 2,117 | 2,067 | 2,100 | +39.5 | +1.9% | 576,300 |
2025/03/17 | 2,060 | 2,067.5 | 2,045 | 2,060.5 | -10 | -0.5% | 317,000 |
2025/03/14 | 2,062 | 2,072 | 2,036.5 | 2,070.5 | +3.5 | +0.2% | 368,000 |
2025/03/13 | 2,080 | 2,080 | 2,056.5 | 2,067 | -19 | -0.9% | 370,900 |
2025/03/12 | 2,024 | 2,102 | 2,021.5 | 2,086 | +41 | +2% | 646,900 |
2025/03/11 | 2,029.5 | 2,068.5 | 2,006 | 2,045 | -18 | -0.9% | 875,800 |
2025/03/10 | 2,050 | 2,091.5 | 2,048 | 2,063 | +2 | +0.1% | 546,900 |
2025/03/07 | 2,049.5 | 2,147.5 | 2,035.5 | 2,061 | -8 | -0.4% | 1,138,500 |
2025/03/06 | 2,085.5 | 2,090 | 2,059.5 | 2,069 | -35 | -1.7% | 591,500 |
2025/03/05 | 2,091.5 | 2,128 | 2,071.5 | 2,104 | +47 | +2.3% | 848,900 |
2025/03/04 | 2,053 | 2,079 | 2,025 | 2,057 | +94 | +4.8% | 1,041,400 |
2025/03/03 | 1,983 | 2,025.5 | 1,961 | 1,963 | +56 | +2.9% | 833,900 |
2025/02/28 | 1,978 | 1,980 | 1,890 | 1,907 | -78.5 | -4% | 1,164,100 |
2025/02/27 | 2,036.5 | 2,037 | 1,984.5 | 1,985.5 | -35.5 | -1.8% | 462,800 |
2025/02/26 | 2,041.5 | 2,048 | 1,982 | 2,021 | -6.5 | -0.3% | 503,400 |
2025/02/25 | 2,023.5 | 2,042.5 | 2,022 | 2,027.5 | +4 | +0.2% | 444,600 |
2025/02/21 | 2,059 | 2,060.5 | 2,017.5 | 2,023.5 | -35.5 | -1.7% | 383,600 |
2025/02/20 | 2,061.5 | 2,069 | 2,038 | 2,059 | -3 | -0.1% | 516,700 |
2025/02/19 | 2,078.5 | 2,102 | 2,046 | 2,062 | -3.5 | -0.2% | 489,000 |
2025/02/18 | 2,083.5 | 2,091.5 | 2,064.5 | 2,065.5 | -23.5 | -1.1% | 589,000 |
1~
50
件表示中 / 999件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 205,600円 | +4.0% | +25.4% | 2.58% | 8.99倍 | 1.18倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
日本新薬 | 370,200円 | +7.9% | +8.9% | 3.35% | 7.92倍 | 1.06倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 198,400円 | +5.0% | +1.5% | 0.00% | 17.03倍 | 4.53倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
科研薬 | 404,100円 | +30.5% | +111.0% | 4.70% | 11.39倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 379,500円 | +14.5% | -2.3% | 2.37% | 13.88倍 | 0.74倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム